PROSPECTIVE ASSESSMENT OF THE DIAGNOSTIC PERFORMANCE OF ENDOSCOPIC ULTRASOUND-GUIDED FINE NEEDLE BIOPSY IN INTRA-ABDOMINAL MASS LESIONS
Completed
- Conditions
- ENDOSCOPIC ULTRASOUND-GUIDED FINE NEEDLE BIOPSY (EUS-FNB)ENDOSCOPIC ULTRASOUND-GUIDED FINE NEEDLE BIOPSY (EUS-FNB), Diagnostic performance, Intraabdominal mass lesion
- Registration Number
- TCTR20200823001
- Lead Sponsor
- Gastroenterological Association of Thailand (GAT)
- Brief Summary
EUS-FNB offered a high diagnostic yield in intra-abdominal solid lesions, especially for the detection of pancreatic cancer and mesenchymal tumor, where the performance of FNA could be limited. It required fewer passes to obtain adequate specimens with comparable technical performance and safety to FNA needles.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Consecutive patients referred for EUS-guided tissue acquisition for intra-abdominal solid lesions, for example, pancreatic mass, lymph node or subepithelial lesion would be included.
Exclusion Criteria
Patients with coagulopathy, thrombocytopenia (platelet count < 50,000 mm3), altered anatomy, contraindications for conscious sedation, pregnancy and those who cannot provide informed consent would be excluded.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method diagnostic performance of endoscopic ultrasound guided fine needle biopsy (EUS-FNB) At the end of intervention sensitivity, specificity, PPV, NPV, AUROC
- Secondary Outcome Measures
Name Time Method /A N/A N/A